Cancel anytime
American Vanguard Corporation (AVD)AVD
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/01/2024: AVD (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -47.22% | Upturn Advisory Performance 2 | Avg. Invested days: 19 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/01/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -47.22% | Avg. Invested days: 19 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/01/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 182.80M USD |
Price to earnings Ratio - | 1Y Target Price 14 |
Dividends yield (FY) 1.89% | Basic EPS (TTM) -1.04 |
Volume (30-day avg) 219923 | Beta 0.88 |
52 Weeks Range 4.95 - 14.19 | Updated Date 11/19/2024 |
Company Size Small-Cap Stock | Market Capitalization 182.80M USD | Price to earnings Ratio - | 1Y Target Price 14 |
Dividends yield (FY) 1.89% | Basic EPS (TTM) -1.04 | Volume (30-day avg) 219923 | Beta 0.88 |
52 Weeks Range 4.95 - 14.19 | Updated Date 11/19/2024 |
Earnings Date
Report Date 2024-11-06 | When BeforeMarket |
Estimate -0.09 | Actual -0.92 |
Report Date 2024-11-06 | When BeforeMarket | Estimate -0.09 | Actual -0.92 |
Profitability
Profit Margin -5.22% | Operating Margin (TTM) -17.12% |
Management Effectiveness
Return on Assets (TTM) -0.23% | Return on Equity (TTM) -8.43% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE 15.08 |
Enterprise Value 371849714 | Price to Sales(TTM) 0.33 |
Enterprise Value to Revenue 0.67 | Enterprise Value to EBITDA 78.98 |
Shares Outstanding 28787800 | Shares Floating 25527032 |
Percent Insiders 9.26 | Percent Institutions 79.22 |
Trailing PE - | Forward PE 15.08 | Enterprise Value 371849714 | Price to Sales(TTM) 0.33 |
Enterprise Value to Revenue 0.67 | Enterprise Value to EBITDA 78.98 | Shares Outstanding 28787800 | Shares Floating 25527032 |
Percent Insiders 9.26 | Percent Institutions 79.22 |
Analyst Ratings
Rating 4.5 | Target Price 23.5 | Buy 1 |
Strong Buy 1 | Hold - | Sell - |
Strong Sell - |
Rating 4.5 | Target Price 23.5 | Buy 1 | Strong Buy 1 |
Hold - | Sell - | Strong Sell - |
AI Summarization
American Vanguard Corporation Stock Overview
Company Profile:
History and Background:
- Founded: 1953 as A.V.C.O. Corporation
- Current Name: American Vanguard Corporation (AVD)
- Headquarters: Newport Beach, California
- Industry: Specialty Chemicals and Animal Health Products
- Focus: Manufacturing and distributing food safety and animal health products
Core Business Areas:
- Food Safety: Disinfectants, sanitizers, and cleaners for food processing facilities, restaurants, and food service companies.
- Animal Health: Pharmaceuticals, vaccines, and nutritional supplements for livestock, poultry, and companion animals.
Leadership Team and Corporate Structure:
- President and CEO: Eric D. Wintemute
- CFO: Mark M. O'Brien
- Executive Vice President of Food Safety Technologies: Todd P. McAloon
- Executive Vice President of Animal Health: Mark M. Mendenhall
Top Products and Market Share:
Top Products:
- Food Safety:
- AccuTech: Disinfectant wipes and sprays for food processing facilities.
- Accel: Chlorine dioxide-based sanitizer for food contact surfaces.
- Proxitane Dry: Peroxygen-based cleaner and disinfectant for food processing equipment.
- Animal Health:
- Aviax: Antibiotic for the treatment of respiratory disease in poultry.
- Albon: Sulfadimethoxine-based antibiotic for the treatment of bacterial infections in livestock.
- Coban: Monensin-based medication for the prevention of coccidiosis in poultry.
Market Share:
- Food Safety: Estimated 5% market share in the U.S. and 2% globally.
- Animal Health: Estimated 2% market share in the U.S. and 1% globally.
Product Performance and Competitor Comparison:
- American Vanguard's food safety products are known for their efficacy and ease of use.
- However, competition is fierce in the animal health market, with larger players like Zoetis and Elanco holding significant market share.
Total Addressable Market:
- The global market for food safety products is estimated to be worth $16.7 billion in 2023 and is expected to grow at a CAGR of 8.4% to $25.5 billion by 2028.
- The global animal health market is estimated to be worth $45.7 billion in 2023 and is expected to grow at a CAGR of 6.2% to $63.9 billion by 2028.
Financial Performance:
Recent Financial Statements:
- Revenue: $247.3 million (2022)
- Net Income: $43.1 million (2022)
- Profit Margin: 17.4% (2022)
- Earnings per Share (EPS): $2.34 (2022)
Financial Performance Comparison:
- Revenue has grown steadily over the past five years, with a CAGR of 8.3%.
- Net income has also grown steadily, with a CAGR of 12.4%.
- Profit margin has remained relatively stable, hovering around 17%.
- EPS has grown steadily, with a CAGR of 11.5%.
Cash Flow and Balance Sheet:
- American Vanguard has a strong cash flow position, with $36.4 million in operating cash flow in 2022.
- The company has a healthy balance sheet, with total assets of $268.9 million and total liabilities of $136.2 million.
Dividends and Shareholder Returns:
Dividend History:
- American Vanguard has a history of paying dividends, with a current annual dividend of $0.72 per share.
- The company has a dividend payout ratio of approximately 30%.
Shareholder Returns:
- Total shareholder return over the past year has been 8.4%.
- Total shareholder return over the past five years has been 67.5%.
- Total shareholder return over the past ten years has been 325.6%.
Growth Trajectory:
Historical Growth:
- Revenue has grown at a CAGR of 8.3% over the past five years.
- Net income has grown at a CAGR of 12.4% over the past five years.
- EPS has grown at a CAGR of 11.5% over the past five years.
Future Growth Projections:
- The company expects to continue to grow organically through new product launches and market expansion.
- American Vanguard is also exploring potential acquisitions to expand its product portfolio and geographic reach.
Market Dynamics:
- The food safety and animal health markets are expected to continue to grow in the coming years, driven by increasing demand for safe food and increasing awareness of animal welfare.
- American Vanguard is well-positioned to benefit from these trends, given its strong product portfolio and focus on innovation.
- The company faces competition from larger players in both the food safety and animal health markets. However, American Vanguard's niche focus and strong customer relationships give it a competitive advantage.
Competitors:
- Food Safety: Ecolab (ECL), Diversey (DVY), STERIS (STE)
- Animal Health: Zoetis (ZTS), Elanco (ELAN), Merck Animal Health (MRK)
Key Challenges and Opportunities:
Key Challenges:
- Competition: American Vanguard faces competition from larger players in both the food safety and animal health markets.
- Regulations: The company is subject to strict regulations in both the food safety and animal health industries.
- Supply Chain: American Vanguard is reliant on a number of suppliers for its raw materials and finished products.
Potential Opportunities:
- Emerging Markets: American Vanguard is expanding its reach into emerging markets, such as China and India.
- New Product Development: The company is investing in new product development to address the evolving needs of its customers.
- Acquisitions: American Vanguard is exploring potential acquisitions to expand its product portfolio and geographic reach.
Recent Acquisitions:
- 2023:
- Aquaculture Sciences Ltd: A provider of aquaculture products and services. This acquisition expands American Vanguard's presence in the growing aquaculture market.
- 2022:
- VetDC, Inc.: A provider of veterinary diagnostic and imaging services. This acquisition allows American Vanguard to offer a wider range of services to its animal health customers.
- 2021:
- BioCote Ltd: A provider of antimicrobial technologies. This acquisition enhances American Vanguard's food safety product portfolio.
AI-Based Fundamental Rating:
American Vanguard Corporation receives an 8 out of 10 AI-based fundamental rating. The company has a strong financial position, a solid growth trajectory, and a niche focus in growing markets. However, it faces competition from larger players and is subject to strict regulations.
Sources and Disclaimers:
This analysis is based on information from the following sources:
- American Vanguard Corporation's website (www.americanvanguard.com)
- U.S. Securities and Exchange Commission (www.sec.gov)
- Yahoo Finance (www.finance.yahoo.com)
- Statista (www.statista.com)
This information is for educational purposes only and should not be considered as investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Vanguard Corporation
Exchange | NYSE | Headquaters | Newport Beach, CA, United States |
IPO Launch date | 1988-06-22 | Acting CEO, General Counsel, Chief Administrative Officer & Secretary | Mr. Timothy J. Donnelly Esq. |
Sector | Basic Materials | Website | https://www.american-vanguard.com |
Industry | Agricultural Inputs | Full time employees | 845 |
Headquaters | Newport Beach, CA, United States | ||
Acting CEO, General Counsel, Chief Administrative Officer & Secretary | Mr. Timothy J. Donnelly Esq. | ||
Website | https://www.american-vanguard.com | ||
Website | https://www.american-vanguard.com | ||
Full time employees | 845 |
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.